Gc-ms analysis and post-mortem distribution of felbamate in humans

Palmer, 1993, Felbamate. A Review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy, Drugs, 45, 1041, 10.2165/00003495-199345060-00008 Wilensky, 1985, Pharmacokinetics of W-554 (ADD 03055) in epileptic patients, Epilepsia, 26, 602, 10.1111/j.1528-1157.1985.tb05699.x Graves, 1993, Felbamate, Ann Pharmacother, 27, 1073, 10.1177/106002809302700913 1993, Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome), New Engl J Med, 328, 29, 10.1056/NEJM199301073280105 Pennel, 1995, Aplastic anemia in a patient receiving felbamate for complex partial seizures, Neurology, 45, 456, 10.1212/WNL.45.3.456 Remmel, 1990, Simultaneous assay of felbamate plus carbamazepine, phenytoin and their metabolites by liquid chromatography with mobile phase optimization, Ther Drug Monit, 12, 90, 10.1097/00007691-199001000-00017 Gur, 1995, Chromatographic procedures for the determination of felbamate in serum, J Anal Toxicol, 19, 499, 10.1093/jat/19.6.499 Poquette, 1995, Isothermal gas chromatographic method for the rapid determination of felbamate concentration in human serum, Ther Drug Monitor, 17, 168, 10.1097/00007691-199504000-00011 Wong, 1996, Totally automated analysis by robotized PrepStation and liquid chromatography: directsample analysis of felbamate, Ther Drug Monitor, 18, 573, 10.1097/00007691-199610000-00009 Kupferberg, 1978, Gas-liquid chromatographic quantitation of valproic acid, 147 Adusumalli, 1991, Felbamate pharmacokinetics in the rat, rabbit, and dog, Drug Metab Dispos, 19, 1116 Levy, 1986, Other Anticonvulsants, 540